Ledger.Open graph →
SEC Form D · filed May 3, 2021

Ashvattha Therapeutics, Inc

Offering
$9.6M
Sold
$7.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
REDWOOD CITY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Sujatha Kannan · Highland, MDDirectorJay Zaveri · Redwood City, CADirectorJeffrey Cleland · San Carlos, CAExec · DirectorGeorge Montgomery · Redwood City, CADirectorKannan Rangaramanujam · Highland, MDExec · DirectorBarbara Slusher · Redwood City, CADirectorPalmer Fox · Dover, DEDirectorAndrew D. Bonanno · MOUNT KISCO, NYExec · DirectorSanju N. Bansal · MCLEAN, VADirectorMelissa A. Mcgrane · Miami, FLExec · DirectorYale J. Baron · New York, NYDirectorAhmed D. Wahla · MOUNT KISCO, NYExec · DirectorMark N. Larow · MCLEAN, VAExec · DirectorClaiborne Williams · Los Angeles, CADirectorMarcus L. Collins · West Palm Beach, FLDirectorMarc L. Collins · West Palm Beach, FLDirectorBarbara Slusher · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗